Breast tendernessMildStarted this weekvia app · Feb 8
"It's not too bad, but it's new since I started the patch and I wanted to check that it's normal."
✓
Red-flag screen: clear. Her report contains no unscheduled bleeding, chest pain, or leg swelling. Reports containing red-flag terms are auto-highlighted and moved to the top of this feed.
Context from product labeling
Breast tenderness (mastalgia) is among the commonly reported effects of systemic estrogen therapy, and is typically early-onset and transient.
Frequency
Common (≥1/100), per labeling
Her timeline
Week 4 · within the early window
Linked medication
Estradiol patch 0.05 mg
Source: transdermal estradiol product labeling (FDA/SmPC). Context only, not a contraindication check or treatment recommendation. Clinical judgment rests with you.
One-tap actions
Editable message to the patient:
Chart-ready note
Patient-reported breast tenderness, mild, onset week 4 of estradiol therapy. No red-flag symptoms reported. Reassurance sent; to review at next visit.
Symptom Tracking Report Across Hormone Therapy · Clinician Review
Wellness report based on patient self-report and brief cognitive sampling. Not a diagnostic tool and not treatment advice. For use by the treating clinician only.
Sarah MitchellMRN ****4521Age 47BMI 24.3LMP 12/12/2025PerimenopausalFollow-up #5 | Apr 15, 2026Week 15 of hormone therapy
Baseline established · First visit · Therapy not yet started
This is Sarah's baseline before starting therapy. There is no trend yet. From the next follow-up onward, the report will show her trajectory over time; the data here helps focus the first visit.
Chart-ready summary
Reported medications
Hormone therapy
Estradiol patch 0.05 mg
Transdermal estrogen (systemic), twice weekly | since Jan 1, 2026
Active
Micronized progesterone 100 mg
Prometrium, at bedtime (systemic) | since Feb 12, 2026
Active (week 6)
Mirena IUD
Levonorgestrel, local (IUD) | uterine protection
Local only
Other medications & supplements (self-reported)
Levothyroxine 75 mcg
Morning, on an empty stomach
Vitamin D 1000 IU
Cholecalciferol | daily
Omega-3
Dietary supplement | daily
Trend over time: symptoms, side effects & therapy events
Symptoms & side effects ↓ lower line = fewer symptoms(0=none, 10=most severe)
Swipe the chart sideways to see the full range
Function & wellbeing ↑ higher line = better functioning(0=very low, 10=optimal)
Red-flag symptoms (unscheduled bleeding, acute pain): none reported by the patient. Self-reports that include red-flag symptoms are highlighted in the clinic's update feed. Absence of a report does not rule out a symptom.
Data cross-check: self-report vs. digital observation
Self-report
Brain fog persists since Follow-up 1. The patient reports ongoing difficulty with focus and memory across the entire tracking period.
Consistent with
Digital observation
Cognitive sampling shows no improvement in focus and memory across follow-ups, consistent with the patient's self-report.
Cognition (THINK) · change since last visit
Game-based sampling, not a neuropsychological assessment. Shown as within-patient change vs. the previous visit, with no external norms. Based on 12 game samples collected between visits.
Processing speedUnchanged
Word retrievalUnchanged
Working memoryUnchanged
Delayed recallUnchanged
Consistent with the patient's self-reported brain fog.
